Adverse Events Decrease

In a recent CASTS study, adverse events after coronary revascularization procedures decreased markedly in California in the first decade of the 21st century. The report, published in the American Journal of Cardiology on August 15, found that the volume of coronary interventions (PCI and CABG) in California decreased, and adverse event rates (death, stroke, acute MI or reintervention) also decreased after the introduction of public reporting and drug-eluting stents in 2003. Lower procedure volume combined with improved outcomes resulted in an annual decrease of >6,000 adverse events by the end of the decade.  See CASTS AJC 08152013